Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | TECH | KYMR | ||
| Company | Reata Pharma | Bio-Techne Corp | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 44.43 | 81.00 | ||
| High | 172.46 | 44.43 | 81.00 | ||
| Low | 172.32 | 44.43 | 81.00 | ||
| Latest | 172.36 | 45.49 | 79.13 | ||
| Change | +0.04 | +1.06 | -0.54 | ||
| % Change | +0.02% | +2.39% | -0.68% | ||
| Volume | 1,988,500 | 210 | 411 | ||
| 20-Day Average Volume | 810,510 | 3,157,710 | 481,661 | ||
| Previous Close | 172.32 | 44.43 | 79.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 50.53 | 83.93 | ||
| 20-Day Raw Stochastic | 97.36% | 7.10% | 27.00% | ||
| 20-Day Relative Strength | 81.56 | 37.56 | 45.82 | ||
| Weighted Alpha | +177.60 | -19.70 | +69.47 | ||
| Today's Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -6.31% since 05/12/26 | -3.05% since 05/12/26 | ||
| Low | 171.96 on 09/19/23 | 43.19 on 05/15/26 | 79.07 on 05/18/26 | ||
| High | 172.46 on 09/25/23 | 47.13 on 05/13/26 | 86.70 on 05/14/26 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -24.99% since 04/17/26 | -7.65% since 04/17/26 | ||
| Low | 168.67 on 09/05/23 | 43.19 on 05/15/26 | 77.64 on 04/30/26 | ||
| High | 172.46 on 09/25/23 | 62.47 on 04/21/26 | 90.10 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -23.73% since 02/19/26 | -6.36% since 02/19/26 | ||
| Low | 88.80 on 06/27/23 | 43.19 on 05/15/26 | 73.31 on 03/24/26 | ||
| High | 172.46 on 09/25/23 | 62.47 on 04/21/26 | 95.90 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | -23.14% since 11/19/25 | +24.96% since 11/19/25 | ||
| Low | 76.54 on 05/10/23 | 43.19 on 05/15/26 | 63.69 on 12/02/25 | ||
| High | 172.46 on 09/25/23 | 72.16 on 01/22/26 | 103.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,956,361 | 6,553,495 | ||
| Shares Outstanding, K | 38,150 | 156,569 | 82,258 | ||
| Annual Sales | 2,220,000 | 1,219,640,000 | 39,210,000 | ||
| Annual Net Income | -311,900,000 | 73,400,000 | -311,350,000 | ||
| Last Quarter Sales | 22,750,000 | 311,420,000 | 34,370,000 | ||
| Last Quarter Net Income | 193,000,000 | 51,050,000 | -69,230,000 | ||
| 60-Month Beta | 1.42 | 1.41 | 2.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 0.53 on 05/06/26 | -0.71 on 04/30/26 | ||
| Earnings Date | 11/14/23 | 08/05/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | 0.080 on 05/18/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 05/18/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.89 | 0.00 | ||